SNN (SNN) Stock Price & Analysis
SNN (SNN) rose 3.23% to USD 31.32 as of June 10, 2026 at 00:44 UTC, according to Nexqual real-time market data.
SNN last closed at USD 30.34; the session ranged USD 30.85–31.4 on volume of 1,356,422 shares. Market capitalization is $13.29B, with a 52-week range of USD 28.4–38.79 (NYQ). Source: Nexqual, June 10, 2026 at 00:44 UTC.
Key Statistics (as of June 10, 2026 at 00:44 UTC)
| Price | USD 31.32 |
|---|---|
| Change | ▲ 3.23% (up) |
| Previous Close | USD 30.34 |
| Open | USD 30.87 |
| Day Range | USD 30.85 – 31.4 |
| 52-Week Range | USD 28.4 – 38.79 |
| Volume | 1,356,422 shares |
| Market Cap | $13.29B |
| Exchange | NYQ |
Technical Analysis (SNN)
Nexqual's technical model rates SNN "NEUTRAL" based on 3 bullish and 3 bearish signals across 124 daily candles, as of June 10, 2026 at 00:44 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 54.22 (neutral) |
| vs SMA50 | Below (USD 31.35) |
| MACD | -0.18 (negative) |
Analyst Ratings (SNN)
Wall Street analysts rate SNN "None" based on 5 analysts, with a mean price target of USD 34.99 (range USD 30–40), per Nexqual as of June 10, 2026 at 00:44 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 5 |
| Mean Target | USD 34.99 |
| High Target | USD 40 |
| Low Target | USD 30 |
| Buy / Hold / Sell | 2 / 3 / 0 |
Earnings (SNN)
| Revenue Estimate | $1.48B |
|---|
Source: Nexqual, June 10, 2026 at 00:44 UTC.
Financials & Fundamentals (SNN)
| Total Revenue | $6.16B |
|---|---|
| Revenue Growth (YoY) | +7.40% |
| Gross Margin | +68.25% |
| Operating Margin | +13.99% |
| Profit Margin | +10.14% |
| ROE | +11.84% |
| Debt / Equity | 62.9 |
| Current Ratio | 2.57 |
| Total Cash | $557.00M |
| Total Debt | $3.33B |
| Free Cash Flow | $876.63M |
Source: Nexqual, June 10, 2026 at 00:44 UTC.
Financial Health Score (SNN)
Nexqual rates SNN's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 00:44 UTC.
| Growth | Solid — Revenue +6% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 68%, operating 14% |
| Balance Sheet | Strong — $557M cash vs $3.33B debt |
| Cash Flow | Solid — FCF $877M, 14% margin |
| Efficiency | Mixed — ROE 12%, ROA 5.3% |
Ownership (SNN)
| Insider Ownership | +0.01% |
|---|---|
| Institutional Ownership | +7.72% |
| Shares Outstanding | 424.43M |
| Float | 2.10B |
| Short % of Float | +0.79% |
Source: Nexqual, June 10, 2026 at 00:44 UTC.
Leadership (SNN)
SNN is led by Deepak S. Nath (age 53), CEO & Director, per Nexqual as of June 10, 2026 at 00:44 UTC.
| CEO & Director | Deepak S. Nath (age 53) |
|---|---|
| CFO & Executive Director | John Terence Rogers (age 56) |
| President of Global Operations | Paul Connolly (age 57) |
| President Research & Development, ENT and Emerging Markets | Vasant Padmanabhan (age 58) |
Major Backers & Investors (SNN)
Notable institutional backers of SNN include Bank of Montreal /CAN/, River Road Asset Management, LLC, Goldman Sachs, according to Nexqual as of June 10, 2026 at 00:44 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Bank of Montreal /CAN/ | 0.82% |
| River Road Asset Management, LLC | 0.76% |
| Goldman Sachs | 0.58% |
| LMR Partners LLP | 0.42% |
| Todd Asset Management LLC | 0.33% |
| Morgan Stanley | 0.33% |
| Brandes Investment Partners L.P. | 0.32% |
| Causeway Capital Management LLC | 0.22% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Dimensional Fund Advisors | 0.28% |
Source: Nexqual, June 10, 2026 at 00:44 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CNMD | CONMED Corporation | USD 36.9 | ▲ 4.95% |
| STE | STERIS plc (Ireland) | USD 212.88 | ▲ 0.25% |
| FMS | Fresenius Medical Care AG | USD 22.35 | ▲ 1.45% |
| OFIX | Orthofix Medical Inc. | USD 9.87 | ▼ 4.08% |
| ZBH | Zimmer Biomet Holdings, Inc. | USD 89.63 | ▲ 2.63% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:44 UTC. This page is informational and not investment advice.